Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:TERN NYSEARCA:YOLO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeTERNTerns Pharmaceuticals$7.05+4.1%$5.00$1.87▼$11.40$616.95M-0.051.08 million shs1.85 million shsYOLOAdvisorShares Pure Cannabis ETF$3.00-7.7%$2.15$1.45▼$3.57$39.06M1.759,705 shs120,705 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceTERNTerns Pharmaceuticals0.00%+15.95%+25.89%+144.79%+8.63%YOLOAdvisorShares Pure Cannabis ETF0.00%+21.46%+42.86%+55.44%-10.71%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationTERNTerns Pharmaceuticals3.9211 of 5 stars3.31.00.04.12.93.30.0YOLOAdvisorShares Pure Cannabis ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceTERNTerns Pharmaceuticals 2.60Moderate Buy$15.63121.63% UpsideYOLOAdvisorShares Pure Cannabis ETF 2.93Moderate Buy$3.00N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookTERNTerns PharmaceuticalsN/AN/AN/AN/A$3.49 per shareN/AYOLOAdvisorShares Pure Cannabis ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateTERNTerns Pharmaceuticals-$88.85M-$1.04N/AN/AN/AN/A-27.35%-26.18%N/AYOLOAdvisorShares Pure Cannabis ETFN/AN/A21.88∞N/AN/AN/AN/AN/ALatest TERN, LBOW, TPVE, and YOLO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2025Q2 2025TERNTerns Pharmaceuticals-$0.28-$0.26+$0.02-$0.26N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthTERNTerns PharmaceuticalsN/AN/AN/AN/AN/AYOLOAdvisorShares Pure Cannabis ETF$0.041.33%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioTERNTerns PharmaceuticalsN/A24.7024.70YOLOAdvisorShares Pure Cannabis ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipTERNTerns Pharmaceuticals98.26%YOLOAdvisorShares Pure Cannabis ETFN/AInsider OwnershipCompanyInsider OwnershipTERNTerns Pharmaceuticals1.50%YOLOAdvisorShares Pure Cannabis ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableTERNTerns Pharmaceuticals4087.51 million86.20 millionNot OptionableYOLOAdvisorShares Pure Cannabis ETFN/A13.02 millionN/ANot OptionableTERN, LBOW, TPVE, and YOLO HeadlinesRecent News About These CompaniesAdvisorShares Pure Cannabis ETF (NYSEARCA:YOLO) Short Interest UpdateAugust 17 at 2:17 AM | americanbankingnews.comAdvisorShares Pure Cannabis ETF (YOLO) Risk - Yahoo FinanceJuly 18, 2025 | finance.yahoo.comDEA in Biden administration thwarted marijuana rescheduling - reportMay 21, 2025 | msn.comThis REIT ETF Just Hit a 52-Week Low. Here’s Why It’s Time to Buy.March 26, 2025 | msn.comCannabis stocks plunge after DeSantis, Griffin win Florida fight against weed legalizationNovember 7, 2024 | nypost.comNCannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's CloseNovember 6, 2024 | benzinga.comAdvisorShares MSOS Climbs 8% As Cannabis Rescheduling Sparks Investor InterestOctober 24, 2024 | benzinga.comAdvisorShares Trust AdvisorShares Pure US Cannabis ETF (ARCA:MSOS), Short Interest ReportOctober 4, 2024 | benzinga.comAdvisorShares Pure Cannabis ETF declares quarterly distribution of $0.0405September 23, 2024 | seekingalpha.comDecibel's $10M Strategy: How It Could Enhance Your Canadian Cannabis PortfolioAugust 27, 2024 | finance.yahoo.comAdvisors should ride the high and invest in cannabis, expert saysAugust 12, 2024 | investmentnews.comICannabis Stocks Under $2: Why Are These Small-Cap Shares Up While Broader Sector Is In The Red?May 20, 2024 | markets.businessinsider.comCannabis stocks jump as Biden administration advances marijuana rescheduling proposalMay 16, 2024 | proactiveinvestors.comETF Prime: Rosenbluth on Spot Ether, Marijuana ETFs, and MoreMay 14, 2024 | etftrends.comECannabis rescheduling unlikely to happen by end of year -- Seeking Alpha surveyMay 11, 2024 | msn.comCannabis stocks pull back after rally on plans to reclassify pot as having ‘moderate to low potential’ for dependenceMay 1, 2024 | msn.comBreaking: DEA Reportedly Moves To Reschedule Cannabis, Stocks Rise Sharply On The NewsApril 30, 2024 | msn.comPot stocks surge on news of cannabis reschedulingApril 30, 2024 | msn.comPot stocks soar on report DEA will ease restrictions on cannabisApril 30, 2024 | msn.comMarijuana banking measure loses potential avenue to passageApril 29, 2024 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesRigetti Soars 30% on Latest Quantum Leap: What It Means Long-TermBy Leo Miller | July 22, 2025How Did Peter Thiel-Backed Crypto Exchange Bullish's IPO Go?By Jordan Chussler | August 14, 2025Tesla Is Balanced on a Knife Edge: Time to Tread CarefullyBy Sam Quirke | August 8, 2025Why Freeport-McMoRan Stock May Hit a New High After Earnings BeatBy Chris Markoch | July 25, 2025Global Value: 3 Stocks Under $10 Riding a Weak DollarBy Chris Markoch | July 30, 2025TERN, LBOW, TPVE, and YOLO Company DescriptionsTerns Pharmaceuticals NASDAQ:TERN$7.05 +0.28 (+4.14%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$7.06 +0.01 (+0.14%) As of 08/15/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of MASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.AdvisorShares Pure Cannabis ETF NYSEARCA:YOLO$3.00 -0.25 (-7.69%) Closing price 08/15/2025 04:10 PM EasternExtended Trading$3.05 +0.05 (+1.67%) As of 08/15/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The AdvisorShares Pure Cannabis ETF (YOLO) is an exchange-traded fund that is based on the Prime Alternative Harvest index. The fund is an actively-managed ETF that seeks long-term capital appreciation by investing in both domestic and foreign cannabis equities, as well as total return swaps of similar securities. YOLO was launched on Apr 17, 2019 and is managed by AdvisorShares. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Applied Materials' Knee-Jerk Sell-Off Is Your Signal to Buy Is Reddit Stock Too Hot, or Just Right? Buffett’s Mystery Buy Revealed, and It’s a Big Bet on UNH AI Glasses to Replace Smartphones? Meta Is Taking Aim at Apple Deere’s Sell-Off Could Be a Long-Term Buying Chance 3 Restaurant Stocks That Will Outperform in Q3 and Q4 Cisco Systems: The Only AI Stock Income Investors Need to Own Gartner’s RSI Just Sank to 11: That’s a Setup You Can’t Ignore Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access